Lamisil Dermgel

Terbinafine, the active ingredient in Lamisil Dermgel, is an allylamine antifungal presented as a gel for cutaneous use. It treats superficial dermatophyte infections such as athlete's foot, ringworm and jock itch in both adults and children, helping to clear skin lesions and relieve associated symptoms. GNH USA supplies Lamisil Dermgel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is an allylamine antifungal used to treat superficial dermatophyte infections of the skin. - Tinea pedis: relieves itching, scaling and erythema caused by athlete's foot. - Tinea corporis: clears ring‑shaped lesions and reduces inflammation. - Tinea cruris: diminishes rash and discomfort in the groin area. - Other superficial dermatophyte infections: eliminates fungal growth on the skin surface.

Common Side Effects: - Local irritation: mild burning or stinging at the application site. - Itching: transient pruritus after gel use. - Redness: erythema around the treated area. - Dry skin: occasional flaking or dryness. - Mild rash: transient localized rash. Serious or Rare Side Effects: - Severe allergic reaction: angioedema or anaphylaxis. - Contact dermatitis: intense skin inflammation. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Severe skin blistering: extensive bullae formation. - Systemic absorption effects: rare liver enzyme elevation.

Before using Lamisil Dermgel, consider the following precautions: - Apply to intact skin only: avoid broken or inflamed areas. - Avoid ocular contact: wash eyes thoroughly if exposure occurs. - Do not combine with other topical antifungals unless directed by a healthcare professional. - Use with caution in patients with known hepatic impairment. - Pregnant or breastfeeding women: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine topical gel has limited systemic interactions, but the following should be considered. Major Interactions (Avoid): - Concurrent systemic terbinafine therapy: risk of cumulative exposure. - Use with topical products containing high alcohol content: may increase irritation. - Known hypersensitivity to allylamine class: avoid application. Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may mask local reactions. - Use under occlusive dressings: can increase percutaneous absorption. - Combination with other antifungal agents: monitor for increased local irritation.